Vontobel Holding Ltd. Cuts Holdings in Agilent Technologies, Inc. $A

Vontobel Holding Ltd. lowered its position in Agilent Technologies, Inc. (NYSE:A) by 18.7% during the second quarter, Holdings Channel.com reports. The fund owned 36,863 shares of the medical research company’s stock after selling 8,489 shares during the quarter. Vontobel Holding Ltd.’s holdings in Agilent Technologies were worth $4,897,000 at the end of the most recent quarter.

Other institutional investors have also recently added to or reduced their stakes in the company. State Street Corp raised its holdings in shares of Agilent Technologies by 1.9% in the 4th quarter. State Street Corp now owns 12,681,792 shares of the medical research company’s stock worth $1,725,611,000 after purchasing an additional 241,029 shares during the period. Geode Capital Management LLC grew its holdings in shares of Agilent Technologies by 0.3% during the 4th quarter. Geode Capital Management LLC now owns 7,425,861 shares of the medical research company’s stock worth $1,006,519,000 after purchasing an additional 25,139 shares during the period. Morgan Stanley grew its holdings in shares of Agilent Technologies by 15.9% during the 4th quarter. Morgan Stanley now owns 5,041,881 shares of the medical research company’s stock worth $686,049,000 after purchasing an additional 692,202 shares during the period. Norges Bank acquired a new stake in Agilent Technologies during the 4th quarter worth approximately $549,158,000. Finally, Cantillon Capital Management LLC increased its position in Agilent Technologies by 0.8% during the 4th quarter. Cantillon Capital Management LLC now owns 3,115,638 shares of the medical research company’s stock worth $423,945,000 after purchasing an additional 23,493 shares in the last quarter. Hedge funds and other institutional investors own 87.41% of the company’s stock.

Wall Street Analysts Forecast Growth

Several research analysts recently commented on the stock. Weiss Ratings upgraded shares of Agilent Technologies from a “hold (c-)” rating to a “hold (c)” rating in a report on Tuesday, June 2nd. Bank of America raised shares of Agilent Technologies from a “neutral” rating to a “buy” rating and dropped their price objective for the stock from $150.00 to $145.00 in a research report on Thursday, May 28th. Wall Street Zen raised shares of Agilent Technologies from a “hold” rating to a “buy” rating in a research note on Sunday, August 2nd. Jefferies Financial Group assumed coverage on shares of Agilent Technologies in a report on Thursday, July 9th. They set a “hold” rating and a $135.00 target price on the stock. Finally, Robert W. Baird upped their price target on shares of Agilent Technologies from $155.00 to $156.00 and gave the stock an “outperform” rating in a research report on Tuesday, May 26th. Two equities research analysts have rated the stock with a Strong Buy rating, thirteen have assigned a Buy rating and four have given a Hold rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $160.24.

Agilent Technologies Stock Performance

Agilent Technologies stock opened at $148.55 on Friday. The stock’s 50 day moving average price is $135.38 and its 200 day moving average price is $125.56. The firm has a market capitalization of $41.96 billion, a PE ratio of 29.83, a price-to-earnings-growth ratio of 2.64 and a beta of 1.25. The company has a debt-to-equity ratio of 0.43, a quick ratio of 1.62 and a current ratio of 2.10. Agilent Technologies, Inc. has a one year low of $108.35 and a one year high of $160.27.

Agilent Technologies (NYSE:A) last released its quarterly earnings results on Wednesday, May 27th. The medical research company reported $1.49 earnings per share for the quarter, topping analysts’ consensus estimates of $1.41 by $0.08. Agilent Technologies had a return on equity of 24.33% and a net margin of 19.55%.The firm had revenue of $1.83 billion during the quarter, compared to analysts’ expectations of $1.80 billion. During the same quarter in the prior year, the business earned $1.31 EPS. Agilent Technologies’s quarterly revenue was up 10.0% compared to the same quarter last year. Agilent Technologies has set its FY 2026 guidance at 6.000-6.100 EPS and its Q3 2026 guidance at 1.480-1.500 EPS. As a group, sell-side analysts expect that Agilent Technologies, Inc. will post 6.03 EPS for the current fiscal year.

Agilent Technologies Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Wednesday, July 22nd. Stockholders of record on Tuesday, June 30th were paid a $0.255 dividend. The ex-dividend date was Tuesday, June 30th. This represents a $1.02 annualized dividend and a dividend yield of 0.7%. Agilent Technologies’s dividend payout ratio is 20.48%.

Agilent Technologies Profile

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.